🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

After-Hours Stock Movers: Nutanix Jumps on Beat, C3.ai Falls on Revenue Miss

Published 08/31/2022, 05:17 PM
Updated 08/31/2022, 05:19 PM
© Reuters.  After-Hours Stock Movers: Nutanix Jumps on Beat, C3.ai Falls on Revenue Miss
DIS
-
BIDU
-
NFLX
-
SMTC
-
GEF
-
CULP
-
FIVE
-
VEEV
-
PSTG
-
NTNX
-
ANAB
-
OKTA
-
MDB
-
AI
-
S
-

After-Hours Stock Movers:

Nutanix (NASDAQ:NTNX) 22% HIGHER; reported Q4 EPS of ($0.17), $0.21 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $385.5 million versus the consensus estimate of $355.3 million. Nutanix sees Q1 2023 revenue of $410-415 million, versus the consensus of $372.63 million. Nutanix sees FY2023 revenue of $1.77-1.78 billion, versus the consensus of $1.66 billion.

C3.ai Inc (NYSE:AI16% LOWER; reported Q1 EPS of ($0.12), $0.12 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $65.3 million versus the consensus estimate of $66.02 million. C3.ai sees Q2 2023 revenue of $60-62 million, versus the consensus of $71.7 million. C3.ai sees FY2023 revenue of $255-270 million, versus the consensus of $310.58 million.

AnaptysBio, Inc. (NASDAQ:ANAB) 15% LOWER; announced top-line data from its HARP Phase 2 trial for the treatment of moderate-to-severe hidradenitis suppurativa (HS). The trial indicated imsidolimab was safe and well tolerated, however did not demonstrate efficacy over placebo in the trials primary endpoint and key secondary endpoints. Clinical development of imsidolimab is being discontinued in hidradenitis suppurativa.

Veeva Systems (NYSE:VEEV) 11% LOWER; reported Q2 EPS of $1.03, $0.02 better than the analyst estimate of $1.01. Revenue for the quarter came in at $534.2 million versus the consensus estimate of $530.71 million. Veeva Systems sees FY2023 EPS of $4.17. Veeva Systems sees FY2023 revenue of $2.14-2.145 billion, versus the consensus of $2.17 billion.

Okta, Inc. (NASDAQ:OKTA) 10% LOWER; reported Q2 EPS of ($0.10), $0.21 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $452 million versus the consensus estimate of $430.64 million. Okta, Inc. sees FY2023 EPS of ($0.73)-$0.70. Okta, Inc. sees FY2023 revenue of $1.81-1.82 billion, versus the consensus of $1.82 billion.

MongoDB (NASDAQ:MDB) 8% LOWER; reported Q2 EPS of ($0.23), $0.05 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $303.7 million versus the consensus estimate of $284.37 million. MongoDB sees Q3 2023 EPS of ($0.19)-($0.16), versus the consensus of ($0.14). MongoDB sees Q3 2023 revenue of $300-303 million, versus the consensus of $294.85 million. MongoDB sees FY2023 EPS of ($0.35)-($0.28), versus the consensus of ($0.21). MongoDB sees FY2023 revenue of $1.196-1.206 billion, versus the consensus of $1.19 billion.

Pure Storage, Inc. (NYSE:PSTG) 8% HIGHER; reported Q2 EPS of $0.32, $0.10 better than the analyst estimate of $0.22. Revenue for the quarter came in at $646.8 million versus the consensus estimate of $636.04 million. Pure Storage, Inc. sees Q3 2023 revenue of $670 million, versus the consensus of $651.62 million. Pure Storage, Inc. sees FY2023 revenue of $2.75 billion, versus the consensus of $2.64 billion.

Semtech (NASDAQ:SMTC) 7% LOWER; reported Q2 EPS of $0.87, $0.02 better than the analyst estimate of $0.85. Revenue for the quarter came in at $209.3 million versus the consensus estimate of $208.29 million. Semtech sees Q3 2023 EPS of $0.60-$0.66, versus the consensus of $0.90. Semtech sees Q3 2023 revenue of $170-180 million, versus the consensus of $215.61 million.

Five Below (NASDAQ:FIVE) 5% HIGHER; reported Q2 EPS of $0.74, $0.05 worse than the analyst estimate of $0.79. Revenue for the quarter came in at $668.9 million versus the consensus estimate of $682.26 million. Five Below sees Q3 2022 EPS of $0.08-$0.19, versus the consensus of $0.29. Five Below sees Q3 2022 revenue of $600-619 million, versus the consensus of $636.5 million. Five Below sees FY2022 EPS of $4.26-$4.56, versus the consensus of $4.83. Five Below sees FY2022 revenue of $2.97-3.02 billion, versus the consensus of $3.07 billion.

Culp Inc (NYSE:CULP) 4% LOWER; reported Q2 EPS of ($0.47), $0.42 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $62.6 million versus the consensus estimate of $69.64 million.

Greif Inc (NYSE:GEF) 3% HIGHER; reported Q3 EPS of $2.35, $0.35 better than the analyst estimate of $2.00. Revenue for the quarter came in at $1.62 billion versus the consensus estimate of $1.6 billion. Greif Inc sees FY2022 EPS of $7.90-$8.10.

SentinelOne, Inc. (NYSE:S) 2% LOWER; reported Q2 EPS of ($0.20), $0.05 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $102.5 million versus the consensus estimate of $95.67 million. SentinelOne , Inc. sees Q3 2023 revenue of $111 million, versus the consensus of $108.2 million. SentinelOne, Inc. sees FY2023 revenue of $415-417 million, versus the consensus of $406.23 million.

Walt Disney (NYSE:DIS) 2% HIGHER; Explores Amazon (NASDAQ:AMZN) Prime-Like Membership Program to Offer Discounts and Perks -- WSJ

Baidu (NASDAQ:BIDU) 1% HIGHER; JPMorgan (NYSE:JPM) upgraded from Neutral to Overweight with a price target of $200.00 (from $160.00).

Netflix (NASDAQ:NFLX) 1% HIGHER; looking to charge advertisers premium prices, aims for Nov. 1 launch of ad-supported tier - WSJ.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.